Common Autoimmune Diseases List: A 2026 Guide by Body System

Written by: Ellie Pranckevicius, FNP-BC, Aesthetic Nurse Practitioner & Aesthetic Injector | Facial Restoration & Regenerative Injectable Specialist, Mirror Plastic Surgery

Key Takeaways

• Autoimmune diseases occur when the immune system attacks healthy tissues, affecting over 23.5 million Americans across more than 80 conditions.
• This guide organizes the 20 most common autoimmune diseases by body system, using 2025–2026 data on prevalence, symptoms, and diagnosis.
• Early warning signs such as unrefreshing fatigue, long-lasting morning stiffness, and unexplained joint pain often appear months or years before diagnosis.
• New peptide therapies, including the 2026 FDA-approved ICOTYDE™ for psoriasis, offer more targeted options for autoimmune management.
• For personalized guidance on autoimmune-related concerns or reconstructive options, schedule a consultation with Mirror Plastic Surgery.

20 Most Common Autoimmune Diseases

The table below groups the 20 most prevalent autoimmune conditions by body system, based on 2025–2026 registry and epidemiological data.

Disease	Estimated U.S. Prevalence	Body System	Notes
Hashimoto’s Thyroiditis	Affects millions of Americans	Endocrine	Leading cause of hypothyroidism, 7–10× more common in women
Psoriasis	~8 million	Skin	30–40% develop psoriatic arthritis within 5–10 years1
Alopecia Areata	Nearly 7 million people in the U.S. have had or will have alopecia areata	Skin	Non-scarring hair loss, clusters with thyroid autoimmunity
Sjögren’s Syndrome	~4 million	Systemic	9:1 female-to-male ratio, average diagnostic delay 6–7 years
Rheumatoid Arthritis	approximately 1.3 million adults	Joints & Muscles	Most common inflammatory arthritis, anti-CCP antibodies highly specific
Lupus (SLE)	approximately 204,000	Systemic	9:1 female-to-male ratio, average diagnostic delay over 6 years
Type 1 Diabetes	~9.5 million globally (2025)	Endocrine	13% global prevalence increase from 2021 to 2025
Celiac Disease	~1% of population, 83% undiagnosed	Digestive	Iron deficiency anemia is the most common adult presentation
Crohn’s Disease	approximately 1 million Americans	Digestive	Can affect any GI segment, transmural inflammation
Ulcerative Colitis	Part of ~50 million IBD/autoimmune burden	Digestive	Limited to colon, continuous mucosal inflammation
Multiple Sclerosis	Tens of millions globally	Nervous System	Relapsing-remitting course most common, demyelinating
Graves’ Disease	Included in top autoimmune conditions	Endocrine	Causes hyperthyroidism, may cause Graves’ ophthalmopathy
Psoriatic Arthritis	Up to 30% of psoriasis patients	Joints & Muscles	Dactylitis and enthesitis are distinguishing early signs
Ankylosing Spondylitis	Axial SpA diagnoses rose +8.9% above pre-pandemic levels in England by 2025	Joints & Muscles	Targets spine and sacroiliac joints, can fuse vertebrae
Vitiligo	~1–2 million Americans	Skin	High autoimmune comorbidity rate, thyroid disease in 25–35%
Scleroderma (Systemic Sclerosis)	Among the most common systemic autoimmune diseases	Systemic	Causes fibrosis of skin and internal organs
Myositis (Dermatomyositis/Polymyositis)	Rare, women 2× more likely than men	Joints & Muscles	Proximal muscle weakness, may involve lungs and skin
Pernicious Anemia	Typically onset ages 60–70+	Systemic	Autoimmune attack on gastric parietal cells, B12 deficiency
Vasculitis	Included in recognized autoimmune conditions	Systemic	Inflammation of blood vessels, can affect multiple organs
Atopic Dermatitis (Eczema)	Around 20% of children worldwide, with regional variation	Skin	Most common inflammatory skin disease, linked to atopic triad

The sections below walk through each body system in more detail and explain how these conditions show up, overlap, and differ in real life. The guide starts with systemic diseases that affect many organs, then moves into joints, digestion, hormones, skin, and the nervous system.

Systemic Autoimmune Diseases Affecting Multiple Organs

Lupus (SLE) is often called “the great imitator” because its joint pain, butterfly facial rash, kidney issues, and fatigue resemble many other conditions. This overlap makes diagnosis challenging and contributes to an average delay of more than six years before many patients receive the correct label and treatment plan.

Sjögren’s Syndrome is a common systemic autoimmune disease that affects an estimated 4 million Americans. Severe dry eyes, dry mouth, fatigue, and joint pain form the classic symptom cluster. The strong female predominance and typical 6–7 year diagnostic delay mean early recognition can significantly improve quality of life.

Scleroderma (Systemic Sclerosis) causes progressive fibrosis of the skin and internal organs, which can stiffen tissues and restrict movement. Some patients develop trigeminal neuralgia, considered one of the most severe pain experiences in medicine. Organ involvement often includes the lungs, kidneys, and gastrointestinal tract, so close monitoring is essential.

Systemic diseases show how one autoimmune process can touch many organs at once. The next group highlights what happens when the immune attack focuses more narrowly on joints and muscles.

Joint and Muscle Autoimmune Conditions

Rheumatoid Arthritis (RA) involves autoreactive T and B cells that produce autoantibodies against synovial joint tissue. Morning stiffness lasting more than one hour helps distinguish RA from osteoarthritis. Anti-CCP antibodies reach about 95% specificity for RA and can appear in blood years before noticeable joint swelling.

Psoriatic Arthritis (PsA) develops in up to 30% of people with psoriasis, usually 5–10 years after skin plaques first show. Dactylitis, often called “sausage digits,” and enthesitis at tendon insertions are early joint signs that help separate PsA from RA.

Ankylosing Spondylitis targets the spine and sacroiliac joints and can gradually fuse vertebrae. A 2026 Lancet Rheumatology study of more than 23 million adults in England reported axial spondyloarthritis diagnoses 8.9% above pre-pandemic expectations by March 2025. From 2023 onward, diagnosis rates in women slightly exceeded those in men, reflecting growing awareness of non-classic presentations.

Joint and muscle conditions often overlap with gut and skin inflammation. The next section focuses on autoimmune diseases that primarily affect the digestive tract.

Digestive System Autoimmune Diseases

Celiac Disease affects approximately 1% of the global population, yet up to 83% of cases remain undiagnosed. Iron deficiency anemia that does not improve with oral iron is the most common adult presentation and should prompt celiac antibody testing.

Crohn’s Disease can involve any part of the gastrointestinal tract from mouth to anus and often causes abdominal pain, persistent diarrhea, and weight loss. It features transmural inflammation and skip lesions, which can lead to strictures, fistulas, and malabsorption over time.

Ulcerative Colitis remains limited to the colon and produces continuous mucosal inflammation, rectal bleeding, urgency, and cramping. Together with Crohn’s disease, it forms the two main types of inflammatory bowel disease that many patients and clinicians manage long term.

Digestive autoimmune conditions often interact with hormone and immune signaling. The next group looks at endocrine diseases where the immune system targets hormone-producing glands.

Endocrine Autoimmune Conditions

Type 1 Diabetes involves immune-mediated destruction of pancreatic beta cells, which leads to absolute insulin deficiency. Global prevalence reached about 9.5 million in 2025, a 13% increase from 8.4 million in 2021. The FDA approved teplizumab in 2022 as the first immunotherapy shown to delay progression from stage 2 to stage 3 type 1 diabetes by a median of 24–48 months.¹

Hashimoto’s Thyroiditis is the most common autoimmune disease in the United States and affects millions of Americans. Lymphocytic infiltration of the thyroid gland causes fatigue, weight gain, cold intolerance, hair loss, and depression. Early in the disease, temporary thyroid inflammation can create hyperthyroid-like symptoms before levels fall.

Graves’ Disease causes the immune system to overstimulate the thyroid, which results in hyperthyroidism. Anxiety, rapid heart rate, unexplained weight loss, and sometimes Graves’ ophthalmopathy with bulging eyes are typical features that prompt evaluation.

Endocrine conditions often show up on the skin and hair. The next section focuses on autoimmune diseases where skin changes are the main clue.

Skin-Focused Autoimmune Diseases

Psoriasis affects more than 8 million Americans and involves overactivation of IL-17, IL-23, and TNF-alpha pathways. In March 2026, the FDA approved ICOTYDE™ (icotrokinra), the first oral IL-23 receptor antagonist peptide for moderate-to-severe plaque psoriasis. Across four Phase 3 trials, about 70% of patients achieved clear or almost clear skin at week 16.¹

Vitiligo affects 0.5–2% of the global population and is now recognized as a systemic autoimmune condition. A 2025 meta-analysis of 10,246 U.S. adults with vitiligo found pooled thyroid disease prevalence of 14.2%. Greater vitiligo extent correlated with higher risk of thyroid disease, type 1 diabetes, and rheumatoid arthritis.

Alopecia Areata affects nearly 7 million people in the U.S. who have had or will have alopecia areata and causes non-scarring hair loss because follicles are suppressed rather than destroyed. It clusters with Hashimoto’s or Graves’ disease in 14–26% of patients, so thyroid screening is often recommended.

Skin and hair changes can precede deeper nervous system involvement. The next section highlights autoimmune disease in the brain and spinal cord.

Nervous System Autoimmune Disease

Multiple Sclerosis (MS) is a chronic demyelinating disease in which immune cells attack myelin and nerve fibers in the central nervous system. Visual disturbances, limb weakness, numbness, balance problems, and cognitive changes often follow a relapsing-remitting pattern. MS has a clinically symptomatic prodromal phase that may last 5 to 10 years or more before diagnosis. A Phase 2a trial of ATX-MS-1467, a four-peptide mixture derived from myelin basic protein, reported a 78% reduction in contrast-enhancing brain lesions after 16 weeks of intradermal treatment in 93 patients with relapsing MS.¹

First Signs of Autoimmune Disease

Many autoimmune diseases share hallmark early symptoms that can appear months or years before a formal diagnosis. The signs below are among the most consistently reported across conditions.

• Unrefreshing fatigue: Fatigue after a full night’s sleep that feels out of proportion to activity often reflects inflammatory cytokine activity and appears in nearly every autoimmune condition.
• Morning stiffness: Stiffness lasting more than 45 minutes and easing as the day goes on suggests inflammatory arthritis such as RA.
• Unexplained joint or muscle pain: Migratory pain that moves between joints, such as knees to wrists, signals early systemic inflammation.
• Skin rashes: Red, itchy, blotchy, or scaly rashes that come and go can indicate lupus or psoriasis. A butterfly-shaped rash across the cheeks and nose strongly points toward lupus.
• Brain fog: Difficulty thinking clearly or finding words often reflects inflammatory cytokines crossing the blood-brain barrier.
• Low-grade fever: A temperature of 37.5–38°C that persists for weeks without infection suggests an immune system running hot.
• Digestive symptoms: Chronic bloating, alternating bowel habits, and new food sensitivities often appear before joint or skin issues because much of the immune system sits in the digestive tract.
• Hair thinning or loss: Brittle hair and patchy bald spots are linked to Graves’ disease and alopecia areata.

Average time from first symptoms to correct diagnosis ranges from about one year for rheumatoid arthritis to more than a decade for celiac disease. When two or more of these signs cluster together, clinicians often recommend autoantibody testing.

Top 10 Most Common Autoimmune Disorders

This ranking uses U.S. prevalence data from the Autoimmune Registry’s February 2025 collaboration with the Mayo Clinic and additional 2025–2026 epidemiological sources.

1. Hashimoto’s Thyroiditis – Affects millions of Americans and is the leading cause of hypothyroidism.
2. Psoriasis – ~8 million Americans, with nearly one-quarter of cases classified as moderate-to-severe.
3. Alopecia Areata – Nearly 7 million people in the U.S. have had or will have alopecia areata, characterized by non-scarring, follicle-suppressing hair loss.
4. Sjögren’s Syndrome – ~4 million Americans, representing a common systemic autoimmune disease.
5. Rheumatoid Arthritis – approximately 1.3 million adults and the most common inflammatory arthritis.
6. Lupus (SLE) – approximately 204,000 Americans, with involvement of multiple organ systems.
7. Celiac Disease – ~1% of the global population, with most cases still undiagnosed.
8. Crohn’s Disease – approximately 1 million Americans, marked by transmural gastrointestinal inflammation.
9. Multiple Sclerosis – Among the most prevalent neurological autoimmune conditions globally, usually with a relapsing-remitting course.
10. Type 1 Diabetes – ~9.5 million globally in 2025, requiring lifelong insulin dependence.

Most Painful Autoimmune Diseases

Pain levels in autoimmune disease fluctuate over time, and the same person with rheumatoid arthritis may rate pain as 2 out of 10 in remission and 9 during a flare.¹ Flares often follow stress, infections, or medication changes. The conditions below consistently carry the highest pain burden in patient reports and clinical studies.

• Rheumatoid Arthritis: Attacks the synovial lining of joints and causes swelling, heat, and progressive destruction, which places RA among the most painful autoimmune conditions.
• Ankylosing Spondylitis: Targets the spine and sacroiliac joints, and vertebral fusion produces chronic, severe axial pain.
• Systemic Sclerosis (Scleroderma): Trigeminal neuralgia, mentioned earlier, ranks this disease among the most painful autoimmune conditions.
• Lupus: Flares can cause intense pain, especially when joints, the lining of the lungs (pleuritis), or the lining of the heart (pericarditis) are involved.
• Psoriatic Arthritis: Enthesitis at tendon and ligament insertions produces pain that often feels more diffuse than classic RA pain.
• Myositis: Painful calcium deposits (calcinosis) in muscles and tissues can develop as the disease progresses and significantly limit mobility.

Triggers and Causes of Autoimmune Disease

Genetic susceptibility alone is usually insufficient to cause autoimmune disease. Instead, environmental factors must act as triggers in genetically susceptible individuals to initiate the autoimmune cascade. The main trigger categories identified in recent research include the following.

• Genetic factors: Genome-wide association studies have identified hundreds of risk loci, especially within the major histocompatibility complex, along with non-HLA genes that regulate cytokine signaling and T cell tolerance.
• Infectious triggers: Certain infections trigger autoimmune symptoms through molecular mimicry, where the immune system cross-reacts with self-tissues that resemble pathogen-derived peptides. Epstein-Barr virus is linked to both lupus and rheumatoid arthritis.
• Hormonal factors: Women have two X chromosomes, and the X chromosome carries many immune-related genes. Estrogen also modulates immune activity, contributing to the 2:1 to 4:1 female-to-male prevalence ratio seen in many autoimmune diseases.
• Gut microbiome alterations: Dysbiosis, or imbalance in gut microbes, is increasingly recognized as a contributing environmental factor across multiple autoimmune conditions.
• Epigenetic modifications: Changes in DNA methylation and histone modification create lasting shifts in gene expression and immune cell function that influence autoimmune risk beyond inherited DNA sequence.
• Pro-inflammatory cytokines: TNF-α, IL-1, and IL-6 coordinate inflammatory reactions across tissues and organs in both chronic autoimmune disease and acute inflammatory states.

Peptide Therapies for Autoimmune Management

Peptide-based approaches to autoimmune management represent one of the most active research areas in 2026. The FDA approved ICOTYDE™ (icotrokinra) on March 17, 2026 as the first targeted oral peptide therapy for an autoimmune disease, moderate-to-severe plaque psoriasis. This approval marked a key milestone in peptide pharmacology. A separate study in Arthritis & Rheumatology identified PEPITEM, a naturally occurring peptide, as a regulator of immune cell migration in inflammatory arthritis, and preclinical models showed reduced inflammation without broad immunosuppression.

Beyond standardized pharmaceutical products, personalized peptide protocols offer a complementary approach to inflammation and autoimmune management. Unlike fixed-dose drugs, these protocols are designed only after reviewing thyroid, liver, kidney, hormone, and metabolic lab panels alongside a detailed medical history. This process helps each peptide stack address the patient’s unique inflammatory drivers and metabolic limits instead of applying a one-size-fits-all formula.

Relevant peptides in inflammation and autoimmune-adjacent protocols often include BPC-157 for systemic inflammation and joint and tissue repair, and KPV for gut microbiome inflammation with NF-κB inhibition. Other stacks may combine immune-modulating peptides with lifestyle, nutrition, and conventional therapies under medical supervision.

Taken together, these advances give patients and clinicians more tools to recognize autoimmune disease earlier and tailor treatment more precisely. For individuals considering reconstructive or aesthetic procedures in the setting of autoimmune disease, partnering with a surgical team experienced in complex immune conditions, such as Mirror Plastic Surgery, can support safer planning and recovery.

---